Track the COMPASS Pathways plc stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, COMPASS Pathways plc has recorded 71 insider filings. Market capitalisation: €1.8bn. The latest transaction was reported on 10 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Goldsmith George Jay. Every trade is free.
71
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€18m
27 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate COMPASS Pathways plc Strong Buy (bullish), based on 16 analysts. Average price target: US$23.75.
35Σ signal
Buys n/a€18m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
23,880 shares@ US$8.528911.4% of flowOrdinary SharesSEC:0001816590-24-000074:0
25 of 71 declarations
About COMPASS Pathways plc
COMPASS Pathways plc is a biopharmaceutical company focused on developing innovative treatments for mental health disorders, including treatment-resistant depression. It is listed on NASDAQ under the ticker CMPS.